| Předmět: |
|
| Zdroj: |
Gastroenterology Week; 5/14/2024, p188-188, 1p |
| Abstrakt: |
A recent study conducted by researchers at Anhui Medical University in China explores the role of interleukin-20 (IL-20) in liver diseases. The study highlights the close relationship between the liver and cytokines, with liver inflammation leading to the release and activation of cytokines. IL-20 has been identified as a pro-inflammatory cytokine that is highly expressed in patients with liver disease, promoting the production of pro-inflammatory molecules involved in disease progression. The researchers suggest that targeting IL-20 could be a potential strategy for mitigating the pro-inflammatory response and offer new possibilities for the treatment and prevention of liver diseases. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
